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Article Information  ABSTRACT 
Received: 12th April 2016  A novel organic–inorganic hybrid film-forming gel for transdermal application was developed 
by poly vinyl alcohol using Di methyl polysiloxane as an inorganic-modifying agent, poly N-
vinyl pyrrolidone as a tackifier and PEG 200 as a plasticizer. The hybrid film-forming gel can 
be directly applied on the skin forms a thin bioadhesive film with transparent and non- greasy 
feeling. The mechanical and bioadhesive properties of films produced from the hybrid gels were 
investigated and the results showed that the incorporation of appropriate Di methyl polysiloxane 
into the PVA matrix significantly improves the mechanical strength and skin adhesion 
properties of the resulting film.  In conclusion, the bioadhesive films formed from organic–
inorganic hybrid gel holds excellent qualities for application on the skin and may provide a 
promising formulation for transdermal delivery of drugs, especially when the patient 
acceptability from an aesthetic perspective of the dosage form is a main consideration.   
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INTRODUCTION 
Transdermal drug delivery system (TDDS) can provide some 
attractive performances over conventional pharmaceutical 
dosage formulations, such as avoiding hepatic first-pass 
metabolism, improving drug bioavailability, reducing dose 
frequency and stabilizing drug delivery profiles1. Compared 
with conventional system such as, transdermal patches, 
ointments and creams, the novel bioadhesive films are 
beneficial in term of ease of preparation, application, reduce 
skin irritation, less greasy, better skin adhesion properties, 
enhance the drug release and increase the patient acceptability 
from an aesthetic perspective2. Several types of polymeric 
materials have been studied over the last decade, in order to 
form bioadhesive films for controlled release of drugs through 
the skin3. These devices can improve the bioavailability of 
drugs that have presystemic hepatic metabolism and 
consequently optimize the pharmacotherapy thus Bioadhesive 
films can be applied to a variety of drugs, are of low cost and 
easy to apply, and allow immediate discontinuation of 
treatment for some side effect4. The attention of many 
researches has turned to the studies of the systems based on 
organic-inorganic hybrid substances. A growing interest is 
attributed to the diverse properties of such systems5. Organic-
Inorganic hybrid materials are considered as next generation 
membrane materials having both film forming properties of a 
polymer and physicochemical stability of an inorganic 
compound. When applied to the polymer surfaces these 
combined materials show improved physical properties without 
neither cracks which are frequently found in inorganic 
materials nor poor thermal stability nor mechanical strength 
which always shadows organic materials6. Due to their 
numerous favorable characteristics, specifically the excellent 
film-forming properties, processability, biocompatibility, non-
toxicity, remarkable hydrophilicity and chemical resistance 
films derived from poly vinyl alcohol (PVA) film-forming gels 
recently have attracted great attention and have been most 
widely used for transdermal delivery7, 8. Meloxicam (MLX) is a 
non-steroidal anti-inflammatory drug used orally to relieve the 
symptoms of osteoarthritis and rheumatoid arthritis has 
numbers of gastrointestinal side effects at high doses on long 
term treatment9. Like other NSAIDs, meloxicam is practically 
insoluble in water which leads to poor dissolution and, hence, 
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variations in its bioavailability10. Therefore, meloxicam needs 
delivery system which modulates gastric side effect and 
delivers the drug to the inflammatory site.  Hence present study 
includes the formation of gel based film for transdermal 
application of drug that will reduce the systemic side effects in 
addition will deliver the drug to the inflammatory site. 
Formation of film will provide better prolong adherence to the 
skin.  In the present work, an organic–inorganic hybrid film-
forming gel was developed for TDDS using PVA as the matrix, 
Di methyl polysilioxane (PDMS) as the modifying agent, 
poly(N-vinyl pyrrolidone) (PVP) as the tackifier and PEG  as 
the plasticizer. The hybrid film-forming gel applied on the skin 
forms a thin and bioadhesive film having pleasing, transparent 
appearance without any greasy feeling. 
 
MATERIAL AND METHODS 
Materials 
Meloxicam was obtained as gift sample from Lupin 
Pharmaceuticals Ltd., Goa, India. Dimethyl polysiloxane and 
D, L Lactic acids were procured from Hi media Laboratories 
Pvt ltd, Mumbai, India.  Polyvinyl alcohol, Dimethyl 
sulfoxaide and Poly ethylene Glycol 200/400 purchased from 
Qualigens fine chemicals, Mumbai, India. All other chemicals 
were of the analytical grade and used as received.  
 
Methods        
Preparation of organic–inorganic hybrid film-forming gel                              
The organic–inorganic hybrid gel was prepared by sol gel 
process11. 5% polyvinyl alcohol solution was prepared in hot 
distilled water, to this specified amount of Dimethyl 
polysiloxane (PDMS) and 2 mL of D, L-lactic acid was added 
to initiate the cross-linking reaction. The mixed solution was 
gently stirred for 12 h at room temperature. Additionally, the 
solution of Meloxicam in DMSO was prepared. Subsequently, 
0.5 g PVP and PEG 200 with or without drug solution were 
added into the aforementioned solution. Again, the mixture was 
stirred slowly for 4 h at room temperature and left overnight to 
remove the entrapped air. The final gel was stored in glass vials 
sealed tightly with an aluminum cap. To study the effect on 
bioadhesion and drug release of various ratios of PVA and 
PDMS were selected. All the formulations F1 to F12 contain 
15 mg meloxicam per grams. The composition of batches F1 to 
F12 are as shown in table 1. 
 
        Table 1: Composition of Meloxicam Hybrid Gel 
Formulation 
Code 
PVA : 
PDMS 
PVP K30 
(g) 
PEG 200 
(g) 
F 1 9 : 1 0.5 1.8 
F 2 8 : 2 0.5 1.6 
F 3 7 : 3 0.5 1.4 
F 4 6 : 4 0.5 1.2 
F 5 5 : 5 0.5 1.0 
F 6 10 : 3 0.5 0.3 
F 7 10 : 4 0.5 0.3 
F 8 10 : 5 0.5 0.3 
F 9 10 : 6 0.5 0.3 
F 10 10 : 7 0.5 0.3 
F 11 10:0 - - 
F 12 10:0 0.5 0.3 
   
Evaluation of Film Forming Hybrid Gel: 
Bioadhesive and mechanical properties of organic–
inorganic hybrid gel 
Measurement of pH 
The pH of various gel formulations was determined using 
digital pH meter. One gram of gel was dissolved in 100 ml 
distilled water and stored for two hours. A mean value of three 
readings was taken. 
 
Viscosity measurements
 
A viscometer (Brookfield DV-II) was used to measure the 
viscosities of the hybrid gels. The spindle was rotated at 10 
rpm. Samples of the gel were allowed to settle for 30 min 
before the measurements were taken. A mean value of three 
specimens was taken12. 
 
Determination of bioadhesive force 
The bioadhesion force is an important parameter for film 
forming formulations since it increases its residence time on 
the skin. The bioadhesive force of hybrid gel was determined 
by using modified method described by13.  A section of 
abdomen mucosal tissue of rat placed onto each glass vial using 
a rubber band and an aluminum cap. The vials with the tissues 
were placed in beaker containing phosphate buffer pH 7.4 
maintained at 36.5°C for 10 min. Next, one vial with a section 
of tissue was connected to the balance and the other vial was 
placed on a height-adjustable pan. Hybrid gel was added onto 
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the abdominal tissue on the other vial. Then, the height of the 
vial was adjusted so that the hybrid gel could be placed 
between the abdominal tissues of both vials. The weights kept 
increase until two vials were attached. Bioadhesive force, the 
detachment stress (gm/sq.cm), was determined from the 
minimal weights that detached two vials. The stronger the 
bioadhesive force, the more it can adhere to the skin surface. 
 
Drug content studies 
Drug content of the gel was determined by dissolving 100 mg 
of gel in about 10 ml of phosphate buffer pH 7.4. From this 1.0 
mL solution was diluted up to 10.0 mL and finally the 
absorbance of prepared solution was measured at 365 nm by 
using UV visible spectrophotometer.  
 
Spreadability
14
  
For the determination of spreadability, excess of sample was 
applied between the two glass slides and was compressed to 
uniform thickness by placing 1000 g weight for 5 min. Weight 
(50 g) was added to the pan. The time required separating the 
two slides, i.e. the time in which the upper glass slide moves 
over the lower plate was taken as measure of spreadability (S) 
S=
M×L
T
 
Where,M is weight tide to upper slide, L is length moved on 
the glass slide and T is time taken. 
 
Preparation of Bioadhesive Organic Inorganic Film  
The accurately weighed quantity of film-forming gel was 
coated on a Teflon plate in a rectangular mould in a dust-free 
atmosphere at room temperature. The film was allowed to dry 
at 40°C for about 72 h, and the completely dried film was 
subsequently peeled off and stored meticulously for the further 
study. 
 
CHARACTERIZATION OF HYBRID FILM  
Mechanical Properties of the film
12
  
In order to evaluate the mechanical properties, completely 
dried film of various formulations of film-forming gels were 
obtain. The film was cut into strips of 1 × 3 cm2 size. Each strip 
was measured by a Vernier Caliper for thickness at five 
different points along the length. Mechanical tests including 
break stress and strain of all samples were performed at room 
temperature using universal testing machine, with load cell 
range 0-40 N. Films of dimension 5 x 1.5 cm2 and free from 
physical imperfections were used for the study. The films were 
held between two clamps at distance of 5 cm. The hybrid films 
were pulled by the clamp at the rate 50 mm/min. The 
mechanical properties tensile breaking stress and % elongation 
were calculated for the film from the above measurements. 
 
Water vapour permeability (WVP) of film 
The water vapor permeability (WVP) was investigated 
according to the method specified in British Pharmacopoeia 
with slight modification. Circular samples with a diameter of 
2.0 cm were cut from the dry film sheets with a scalpel. 
Twenty-milliliter glass vials with an opening of 1.5 cm 
diameter were filled with approximately 10 g of distilled water, 
and the vials were weighed before sealing.  The vials covered 
with the circular film samples were sealed tightly and placed 
into a test chamber. The inside environment of the test chamber 
was kept at 37°C and a relative humidity of 65%. They were 
kept for 24 h and weighed at predetermined intervals after 
removal from the test chamber. The control for this experiment 
was vial without film sample which represented 100% water 
vapor permeability. 
 
In vitro release study 
The release of drug through diffusion membrane as the 
diffusion barrier was examined using a modified Franz-type 
diffusion cell. Diffusion membrane with a diameter of 1.5 cm 
was mounted on the diffusion barrier in the donor 
compartment. After acclimation for 1 h, the receptor 
compartment was filled with phosphate buffer pH 7.4. The 
solution in the receptor compartment was thermoregulated with 
a water bath at 37 ± 0.5°C and stirred with a small magnetic 
bar. Samples (2 mL) were withdrawn at 1, 2, 3, 4, up to 12 
hours. Subsequently, the receptor compartment was replenished 
to its marked volume with fresh buffer solution. Addition of 
solution to the receptor compartment was performed with great 
care to avoid trapping air beneath the membrane samples 
.  
Appearance of Film on Skin 
The appearance of film-forming gel was observed by applying 
gel on the inner surface of the forearm of volunteers at room 
temperature and the changes occurring in the appearance of the 
film was noted. 
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RESULT AND DISCUSSION 
Bioadhesive and mechanical properties of organic–
inorganic hybrid gel 
The gel of all the batches was evaluated for their pH. From 
table 2 it was found the pH of all the formulations from F1 to 
F12 ranges from 5.9 to 7.2 that come in the range of normal 
skin pH. Bioadhesive is an essential property of film for a 
transdermal therapeutic product11. The bio adhesion of PVA–
PDMS–PVP–PEG films found to be markedly increased with 
the increase in the amount of PDMS as illustrated in table 2 
probably as a result of cross-linking of PDMS can increase 
intermolecular force and strengthen the hydrogen bond action 
due to increasing amount of Si-O- in the system. Additionally 
these factors can lead to increase in viscosity as depicted in 
table 2. One of the most important parameter is the content of 
active ingredient in the formulations. From the table 2 it was 
found that the drug content of all the formulations F1 to F12 
was more than 89.2 % (average drug content 94.67±1.024%). 
All the formulations from F1 to F12 had the spreadability 
ranging from 19.59 to 25.59 (average spreadability 23.41 
(gm.cm/sec)). 
 
Mechanical properties of organic–inorganic hybrid films 
The topical application of polymeric films depends on their 
mechanical properties at room temperature. The stress–strain 
readings for PVA and its hybrid films with different PDMS 
content are shown in table 3. It can be seen that neat PVA film 
(F11) was very brittle with high level of mechanical stresses 
due to strong crystallization. PDMS had a significant impact on 
mechanical properties of the hybrid films. Compared with 
PVA–PVP–PEG (F12), the stress of the hybrid films was 
markedly improved with increasing PDMS content and the 
degree of elongation decreased with the increase in PDMS, 
which can be attributed to the strong interaction between PVA 
and silica. So, the addition of PDMS into the bulk of PVA 
matrix was rational to improve toughness of the hybrid films in 
order to ensure excellent application performance.  
 
The thickness (mm) of all the films of size 1 × 3 cm2 along the 
length was found to be 0.0724 ± 0.021mm. It was known that 
the occlusion of skin not only resulted in hydration but also 
alter other ecological factors and often cause severe skin 
irritation15. Therefore, WVP of films was an important feature 
of a drug delivery system that was supposed to be on the skin 
for a prolonged period of time. The WVP of PVA and its 
hybrid films was assessed according to British Pharmacopoeia. 
The WVP of control value and PVA film was about 0.185 g 
(cm2 24 h)−1 and 0.062 g (cm2 24 h)−1, respectively. The 
relatively low WVP value of PVA film indicates large number 
of crystalline regions that are impermeable to water vapour 
diffusion. It can be observed from figure 1 and figure 2 that the 
content of PDMS had a considerable effect on the WVP of 
PVA films. But, a parabolic relationship was observed between 
the WVP of PVA films and the PDMS content. The WVP 
values firstly increased with the increase in the PDMS/ (PVA + 
PDMS) ratio (from F1to F3) and then rapidly decreased with a 
further increase in the content of PDMS. PDMS can effectively  
disorder the PVA chains and hence decrease the crystalline 
region of PVA, which made water vapour diffusion easier. The 
self-cross-linked reaction of PDMS molecules proceeded at 
higher PDMS content (PDMS/ (PVA + PDMS) and thereby, 
the destruction of crystalline regions of PVA was depressed 
due to the decrease in cross-link reaction between PVA and 
PDMS 
 
Characterization of Film 
In vitro Release study 
The results of release of meloxicam from PVA and its hybrid 
films across dialysis membrane are shown in figure 3, 4, and 5. 
The formulation F1 to F5 (Figure 3) show the 8.94 ± 0.41, 
11.52 ± 0.94, 24.67 ± 0.78, 23.88 ± 0.93, 7.75 ± 0.67 % release 
at 1hr while it shows the 77.37 ± 2.24, 83.79 ± 1.23, 92.18 ± 
1.06, 95.2 ± 2.18, 74.45 ± 0.93 % release at 10 hr. From the 
above formulations F4 containing 40% PDMS showed 
maximum release i.e. 95.2 ± 2.18. The above result shows that 
the formulation containing PDMS in the ratio of 20% to 40% 
shows the maximum drug release. Batch F6 to F10 (Figure 4) 
showed 8.71 ± 1.42, 22.09 ± 0.86, 23.51 ± 1.68, 5.02 ± 1.47, 
3.15 ± 0.40 % release at 1hour while these batches shows 79.79 
± 0.90, 95.06 ± 1.30, 93.33 ± 0.78, 74.83 ± 2.50, 57.52 ± 0.65 
% release at 10 hr.  
 
The above result shows that the formulation containing 10:3 
and 10:4 (PVA: PDMS) i.e. batch F7 and F8 shows maximum 
drug release. F11 (PVA) and F12 (PVA–PVP–PEG) as shown 
in figure 5, showed more sustained release of drug i.e. 70.34 ± 
1.01 and 74.20 ± 2.17 after 10 hr which is less than the 
formulation containing PDMS. Such effect may be due the 
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diffusion process of drug within the film become very difficult 
due to the crystallization of PVA chain. However, the % 
release of meloxicam from PVA–PVP–PEG film was found to 
be slightly higher than that from PVA film, which can 
concluded that addition of PVP and PEG enhanced the 
diffusion of drug, as the crystallization of drug in the matrix 
may cause a reduction in drug diffusion16. From the results 
discussed above batch F4 shows better results for bioadhesion 
study along with the percent drug release study. The PVP in 
film can improve the drug diffusion because the anti-nucleating 
effect of PVP can convert the crystalline drug into the 
amorphous state. In addition, PEG may create a space and a 
large free volume within the film, therefore enhancing drug 
diffusion. As observed from figure 3, 4and 5 introduction of 
PDMS can exert a strong impact on the drug diffusion through 
the hybrid films. Especially, the % release of drug was 
increased when the PDMS/ (PVA + PDMS) ratio is between 
20% and 40% and then rapidly decreased with a further 
increasing PDMS. The studies above have clearly shown that 
the appropriate amount of PDMS can effectively increase the 
amorphous region of the matrix and accordingly enhance drug 
diffusion. On the other side, the excessive PDMS leading to 
self-crosslinked reaction of PDMS made the film more 
compact and thereby made drug diffusion more difficult. 
Table 2: Evaluation of Film Forming Hybrid Gel 
Formulation 
Code 
pH 
Viscosity 
(cps) 
Bioadhesive 
force (g/sq.cm) 
% Drug content 
Spreadability 
(gm.cm/sec) 
F 1 6.79 ± 0.09 30440 2.029 ± 0.06 92.84 ± 1.04 22.94 ± 0.73 
F 2 6.95 ± 0.14 31620 2.494 ± 0.017 89.28 ± 1.83 24.57 ± 1.08 
F 3 6.89 ± 0.23 34740 2.682 ± 0.06 96.71 ± 1.24 25.59 ± 0.47 
F 4 6.88 ± 0.06 35900 3.031 ± 0.041 97.23 ± 0.68 23.37 ± 0.54 
F 5 7.23 ± 0.03 36680 3.152 ± 0.022 89.65 ± 0.53 24.90 ± 0.73 
F 6 6.84 ± 0.25 30435 2.587 ± 0.012 94.65 ± 1.05 21.99 ± 0.51 
F 7 6.70 ± 0.21 31920 2.705 ± 0.026 97.84 ± 0.34 22.40 ± 0.53 
F 8 6.91 ± 0.02 33480 2.983 ± 0.033 96.38 ± 1.13 23.20 ± 1.10 
F 9 7.06 ± 0.05 35120 3.000 ± 0.08 96.29 ± 1.35 24.45 ± 0.87 
F 10 6.92 ± 0.12 37640 3.211 ± 0.019 95.92 ± 1.05 25.68 ± 0.90 
F 11 5.95 ± 0.5 28540 1.425 ± 0.08 91.33 ± 2.04 19.59 ± 0.65 
F 12 6.18 ± 0.28 28680 1.544 ± 0.05 92.55 ± 1.02 22.31 ± 0.83 
 
         Table 3. Mechanical properties of organic–inorganic hybrid films 
Formulation 
Code 
Breaking 
Stress (gm/cm
2
) 
% Elongation Thickness  (mm) 
Water permeability test 
gm (cm
2
24h)
−1
 
F 1 3.312 86 0.0724 ± 0.02 0.070 
F 2 3.64 74 0.0719 ± 0.02 0.094 
F 3 4.14 76 0.0723 ± 0.01 0.105 
F 4 4.74 48 0.0714 ± 0.02 0.083 
F 5 5.32 28 0.0720 ± 0.02 0.073 
F 6 2.59 68 0.0734 ± 0.01 0.100 
F 7 3.65 51 0.0718 ± 0.02 0.110 
F 8 4.92 51 0.0724 ± 0.03 0.122 
F 9 5.445 38 0.0724 ± 0.02 0.098 
F 10 6.19 29 0.0722 ± 0.02 0.091 
F 11 5.71 15 0.0723 ± 0.01 0.062 
F 12 3.04 92 0.0724 ± 0.02 0.185 
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APPEARANCE OF FILM ON SKIN 
Film-forming gel was applied on the inner surface of the 
forearm of volunteer at room temperature. Figure 6 shows the 
appearance of film after 2 hrs of application. The organic–
inorganic hybrid film-forming gel was transparent, jelly-like 
substance with good flexibility and adhesive property, easy to 
apply on the skin surface. The viscous gel turned entirely into a 
solid film and adhered tightly with skin after acclimation for 
about 10 min. The resultant film can form a smooth hard outer 
surface which may reduce the risk of polluting clothes or being 
rubbed off by clothes. The film was maintained and 
satisfactorily adhered on skin. Film formed on skin was quite 
different from traditional ointments and creams. In addition 
without any greasy feeling, the film formed from organic–
inorganic materials not only can maintain suitable skin 
adhesive properties to ensure long time dressing, but also have 
enough strength to resist abrasion. This result indicated that 
PDMS can exert a significant influence on the physicochemical 
properties and application performances of the resultant film. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: WVP of PVA and Hybrid Films F1- F5 
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Figure 2: WVP of PVA and Hybrid Films Form F6 - F10 
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Figure 3: Percentage drug release of batch F1-F5   Figure 4: Percentage drug release of batch F6-F10 
PV
A 10 20 30 40 50
C
O
N
TR
O
L
0.00
0.05
0.10
0.15
0.20
F1
F2
F3
F4
F5
PVA (F11)
Ratio of PDMS (%)
W
V
P
 g
m
(c
m
2
2
4
h
)_
1
 Taksande et. al
 
Formulation and characterization of organic- inorganic hybrid film for transdermal drug delivery 
 
 
Journal of Applied Pharmaceutical Research  July – September 2016  Volume 4 Issue 3  14 
0 2 4 6 8 10
0
20
40
60
80
100
F11
F12
TIME (hrs)
%
 D
R
U
G
 R
E
L
E
A
S
E
    
Figure 5: Percentage drug release of batch F11-F12   Figure 6: Appearance photographs of Hybrid films after 2 hrs 
CONCLUSIONS 
A novel organic–inorganic hybrid film forming gel composed 
of PVA, Di methyl polysilioxane, PVP and PEG 200 was used 
to prepare transdermal film. Film formed on skin was quite 
different from traditional ointments and creams. Apart from 
without any greasy feeling, the film formed from organic–
inorganic materials not only can maintain suitable skin 
adhesive properties to ensure long time dressing, but also have 
enough strength to resist abrasion. This film-forming gel was 
colorless, transparent with good flexibility and adhesion 
property with an aesthetical appearance. This result indicated 
that PDMS can exert a significant influence on the 
physicochemical properties and application performances of 
the resultant film. In nutshell, the novel formulation of hybrid 
gel may provide a realistic explanation to the aforementioned 
problems associated with the use of polymer gel as a film 
forming agent for TDDS. 
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